newscontact us

Cesca Therapeutics’ Management Delivers Keynote Speech at the 2017 Shenzhen International Precision Medicine Summit

RANCHO CORDOVA, CA, April 7, 2017 – Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that Dr. Xiaochun (Chris) Xu, Chairman and Interim Chief Executive Officer, delivered the keynote speech, entitled, “Cell Therapy – The Next Wave of Future Medicine,” at the 2017 Shenzhen International Precision Medicine Summit, which took place yesterday and today (April 6-7) in Shenzhen, China. The summit was organized in honor of James D. Watson, Ph.D., Nobel Laureate who discovered the double helix structure of DNA in 1953 and later made a significant contribution to the Human Genome Project.(more)